Cargando…

Management of rheumatoid arthritis in Poland – where daily practice might not always meet evidence-based guidelines

INTRODUCTION: International recommendations are intended to help rheumatologists in the effective management of rheumatoid arthritis (RA) through an evidence-based approach. This research aimed to evaluate management patterns and associated difficulties encountered by rheumatologists in daily practi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Batko, Bogdan, Korkosz, Mariusz, Juś, Anna, Wiland, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2019
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425259/ https://www.ncbi.nlm.nih.gov/pubmed/34522257 http://dx.doi.org/10.5114/aoms.2019.84092

Ejemplares similares

Methotrexate treatment for rheumatoid arthritis in Poland: Retrospective analysis of patients in routine clinical practice
por: Świerkot, Jerzy, et al.
Publicado: (2018)

Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study
por: Batko, Bogdan, et al.
Publicado: (2017)

Physician Adherence to Treat-to-Target and Practice Guidelines in Rheumatoid Arthritis
por: Batko, Bogdan, et al.
Publicado: (2019)

Tofacitinib in the treatment of patients with rheumatoid arthritis: position statement of experts of the Polish Society for Rheumatology
por: Kucharz, Eugeniusz J., et al.
Publicado: (2018)

Rheumatoid Vasculitis: Is It Always a Late Manifestation of Rheumatoid Arthritis?
por: Anwar, Muhammad M, et al.
Publicado: (2019)

Jagiellonian University and allied rheumatology centers across the country have launched Poland’s first registry on inflammatory rheumatic diseases: How the Real World Evidence Registry in Rheumatic Diseases in Poland has finally become a fact. A long, steep road successfully completed
por: Korkosz, Mariusz
Publicado: (2023)

Evaluation of Risk Factors for Falls in Patients with Rheumatoid Arthritis
por: Mikos, Marcin, et al.
Publicado: (2020)

Indirect Costs of Rheumatoid Arthritis Depending on Type of Treatment—A Systematic Literature Review
por: Batko, Bogdan, et al.
Publicado: (2019)

10B. Integrative Management of Rheumatoid Arthritis: Where the Rubber Meets the Road
por: Manek, Nisha
Publicado: (2013)

Where traditional Chinese medicine meets Western medicine in the prevention of rheumatoid arthritis
por: Jakobsson, Per‐Johan, et al.
Publicado: (2022)

Editorial Comment on I. Sudoł-Szopińska, E. Kontny, W. Maśliński, M. Prochorec-Sobieszek, B. Kwiatkowska, K. Zaniewicz-Kaniewska, A. Warczyńska The pathogenesis of rheumatoid arthritis in radiological studies. Part I: Formation of inflammatory infiltrates within the synovial membrane and I. Sudoł-Szopińska, K. Zaniewicz-Kaniewska, A. Warczyńska, G. Matuszewska, F. Saied, W. Kunisz The pathogenesis of rheumatoid arthritis in radiological studies. Part II: Imaging studies in rheumatoid arthritis
por: Wiland, Piotr
Publicado: (2012)

Real-world experience of rituximab biosimilar GP2013 in rheumatoid arthritis patients naïve to or switched from reference rituximab
por: Łosińska, Katarzyna, et al.
Publicado: (2023)

Assessment of the Effect of Methotrexate Therapy on Bone Metabolism in Patients with Rheumatoid Arthritis
por: Świerkot, Jerzy, et al.
Publicado: (2015)

Long-term drug effectiveness and survival for reference rituximab in rheumatoid arthritis patients in an ordinary outpatient clinic
por: Łosińska, Katarzyna, et al.
Publicado: (2022)

Remission or Not Remission, That’s the Question: Shedding Light on Remission and the Impact of Objective and Subjective Measures Reflecting Disease Activity in Rheumatoid Arthritis
por: Brkic, Alen, et al.
Publicado: (2022)

Always Give Credit Where Due
Publicado: (1897)

Probing the use of fluorescence spectroscopy as a novel diagnostic tool in patients with rheumatoid arthritis: Applicability in the detection of secondary amyloidosis
por: Jeka, Sławomir, et al.
Publicado: (2012)

Exploring the Diverse Immune and Genetic Landscape of Psoriatic Arthritis
por: Batko, Bogdan
Publicado: (2021)

Biomarkers for Treatment Response in Rheumatoid Arthritis: Where are they?
por: Zhao, Sizheng Steven, et al.
Publicado: (2020)

Work instability and associated factors among patients with rheumatoid arthritis in Greater Poland
por: Schmidt, Wiktor, et al.
Publicado: (2020)

Tofacitinib in the treatment of active rheumatoid arthritis – single-centre experience
por: Madej, Marta, et al.
Publicado: (2019)

Patient-Centered Care in Psoriatic Arthritis—A Perspective on Inflammation, Disease Activity, and Psychosocial Factors
por: Batko, Bogdan
Publicado: (2020)

Cadmium Body Burden and Inflammatory Arthritis: A Pilot Study in Patients from Lower Silesia, Poland
por: Markiewicz-Górka, Iwona, et al.
Publicado: (2022)

Differential Associations of Inflammatory and Endothelial Biomarkers with Disease Activity in Rheumatoid Arthritis of Short Duration
por: Klimek, Ewa, et al.
Publicado: (2014)

Lack of assortative mating might explain reduced phenotypic differentiation where two grasshopper species meet
por: Morgan‐Richards, Mary, et al.
Publicado: (2021)

Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis
por: Iwaszko, Milena, et al.
Publicado: (2018)

Polymorphisms within Genes Involved in Regulation of the NF-κB Pathway in Patients with Rheumatoid Arthritis
por: Gębura, Katarzyna, et al.
Publicado: (2017)

Where to Stand with Stromal Cells and Chronic Synovitis in Rheumatoid Arthritis?
por: Brondello, Jean-Marc, et al.
Publicado: (2019)

Functional genomics and rheumatoid arthritis: where have we been and where should we go?
por: Jarvis, James N, et al.
Publicado: (2010)

Where is the Large Hadron Collider that might destroy Earth?
Publicado: (2008)

Alterations in Both the Activatory and Inhibitory Potential of Peripheral Blood CD4+ T Cells in Rheumatoid Arthritis Patients Correlate with Disease Progression
por: Kosmaczewska, Agata, et al.
Publicado: (2013)

Budget impact analysis and treatment availability with biosimilar TNF inhibitors in rheumatic diseases in Poland: real-world evidence using a nationwide database
por: Stajszczyk, Marcin, et al.
Publicado: (2023)

TNF-α Inhibitors Decrease Classical CD14(hi)CD16− Monocyte Subsets in Highly Active, Conventional Treatment Refractory Rheumatoid Arthritis and Ankylosing Spondylitis
por: Batko, Bogdan, et al.
Publicado: (2019)

Antiplatelets in acute coronary syndrome in Poland – from guidelines to clinical practice
por: Tubek, Stanisław, et al.
Publicado: (2021)

Biosimilar switching – current state of knowledge
por: Wiland, Piotr, et al.
Publicado: (2018)

Blood Monocyte Subsets and Selected Cardiovascular Risk Markers in Rheumatoid Arthritis of Short Duration in relation to Disease Activity
por: Klimek, Ewa, et al.
Publicado: (2014)

Drug Retention and Safety of Secukinumab in a Real-World Cohort of Ankylosing Spondylitis and Psoriatic Arthritis Patients
por: Moskal, Mateusz, et al.
Publicado: (2022)

Senescence: why and where selection gradients might not decline with age
por: Roper, Mark, et al.
Publicado: (2021)

Serum concentration of dickkopf-related protein 1 (DKK1) in psoriatic arthritis in the context of bone remodelling
por: Biedroń, Grzegorz, et al.
Publicado: (2023)

MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial
por: Behrens, Frank, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_skbl3turj09nnlsc1fga3cjupt